Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELE | P16581 | 15/20 | 0.68 |
| ▸ | CD69 | Q07108 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SELL | P14151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17881694 | 1.00 | SELE (0.68) | SELECD69MAPK1SELL | |
| SCHEMBL17877663 | 0.94 | SELE (0.57) | SELESELL | |
| SCHEMBL17777230 | 0.94 | SELE (0.58) | SELECD69SELL | |
| SCHEMBL17881673 | 0.94 | SELE (0.58) | SELECD69SELL | |
| SCHEMBL17877662 | 0.93 | SELE (0.58) | SELECD69SELL | |
| SCHEMBL17881676 | 0.92 | SELE (0.55) | SELESELL | |
| SCHEMBL18027947 | 0.92 | SELE (0.55) | SELESELL | |
| SCHEMBL17881708 | 0.92 | SELE (0.55) | SELESELL | |
| SCHEMBL16661869 | 0.92 | SELE (0.55) | SELESELL | |
| SCHEMBL16659817 | 0.89 | SELE (0.74) | SELEMAPK1SELL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9867841-B2 | Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells | GLYCOMIMETICS, INC. (US) | 2018-01-16 | — | — | US | disclosed |
| US-20160184339-A1 | Compounds, Compositions and Methods Using E-Selectin Antagonists for Mobilization of Hematopoietic Cells | GLYCOMIMETICS, INC. (US) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160184339-A1 | Compounds, Compositions and Methods Using E-Selectin Antagonists for Mobilization of Hematopoietic Cells | SELE, SELP, SELPLG | SELE 1/4885CD69 34/4885MAPK1 2029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.